These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1382834)

  • 1. Co-ordinate expression of c-fos, p53 and cytokeratin genes during the alteration of growth of human hepatoma cells. mRNA levels measured by reverse transcription and polymerase chain reaction.
    Kaneko Y; Tsukamoto A; Korokawa K
    Cancer Lett; 1992 Sep; 66(2):155-64. PubMed ID: 1382834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novobiocin modulates cytokeratin assembly and differentiation of human hepatoma cells induced by butyrate and teleocidin.
    Tsukamoto A; Kaneko Y; Kurokawa K
    Cancer Lett; 1991 Oct; 60(1):51-7. PubMed ID: 1717136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alteration of cytokeratin 18 molecule and its mRNA expression during tumor transformation in hepatoma.
    Liu YH; Pei RJ; Yeh CC; Lee KY; Yeh KT; Hsu YH; Ho CC; Lai YS
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):243-53. PubMed ID: 9261884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vacuole formation and cytokeratin rearrangement of hepatoma cells induced by teleocidin are not associated with down-regulation of protein kinase C.
    Kaneko Y; Tsukamoto A; Kurokawa K
    Cancer Res; 1991 May; 51(10):2677-82. PubMed ID: 1708698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thapsigargin, an inhibitor of endoplasmic reticulum Ca(2+)-ATPase, enhances c-fos expression but antagonizes vacuole formation of human hepatoma cells induced by teleocidin.
    Tsukamoto A; Kaneko Y; Kurokawa K
    Biochim Biophys Acta; 1993 May; 1177(1):31-6. PubMed ID: 8485167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
    Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
    Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
    Wu F; Nishioka M; Fujita J; Murota M; Ohtsuki Y; Ishida T; Kuriyama S
    Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of c-myc expression by transforming growth factor beta 1 in human hepatoma cell lines.
    Ito N; Kawata S; Tamura S; Takaishi K; Saitoh R; Tarui S
    Jpn J Cancer Res; 1990 Mar; 81(3):216-9. PubMed ID: 2161812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of biological responses to polymeric biomaterials by RT-PCR analysis IV: study of c-myc, c-fos and p53 mRNA expression.
    Kato S; Akagi T; Sugimura K; Kishida A; Akashi M
    Biomaterials; 2000 Mar; 21(5):521-7. PubMed ID: 10674817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and nuclear levels of p53 protein and proliferating cell nuclear antigen in human hepatoma cells cultured with tumor promoters.
    Kaneko Y; Tsukamoto A
    Cancer Lett; 1995 May; 91(1):11-7. PubMed ID: 7750085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the tumor promoter teleocidin on human hepatoma cells in tissue culture.
    Hayashida N; Kaneko Y; Nishi T; Miyazaki J; Endo Y; Oda T
    Gan; 1982 Aug; 73(4):534-8. PubMed ID: 6295866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of regucalcin modulates tumor-related gene expression in cloned rat hepatoma H4-II-E cells.
    Tsurusaki Y; Yamaguchi M
    J Cell Biochem; 2003 Oct; 90(3):619-26. PubMed ID: 14523995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation.
    Pogribny IP; James SJ
    Cancer Lett; 2002 Feb; 176(2):169-74. PubMed ID: 11804744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of androgen receptor mRNA in human hepatocellular carcinomas and hepatoma cell lines.
    Nakagama H; Gunji T; Ohnishi S; Kaneko T; Ishikawa T; Makino R; Hayashi K; Shiga J; Takaku F; Imawari M
    Hepatology; 1991 Jul; 14(1):99-102. PubMed ID: 1648543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An altered repertoire of fos/jun (AP-1) at the onset of replicative senescence.
    Irving J; Feng J; Wistrom C; Pikaart M; Villeponteau B
    Exp Cell Res; 1992 Sep; 202(1):161-6. PubMed ID: 1511730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of teleocidin on the morphology and c-myc expression of hepatoma cells which are not inhibited by protein kinase antagonists.
    Kaneko Y; Toda G; Oka H
    Biochem Biophys Res Commun; 1987 May; 145(1):549-55. PubMed ID: 3109417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
    Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M
    Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of tagalsin on p53 and Bcl-2 expression in hepatoma H(22) tumor-bearing mice].
    Song XQ; Guo YL; Wang BG; Sun SJ; Yao RY
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):499-503. PubMed ID: 22093625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of down-regulation-resistant protein kinase C in teleocidin inhibition of cell proliferation and calcium mobilization induced by epidermal growth factor and vasopressin in human hepatoma cells.
    Kaneko Y; Tsukamoto A; Kurokawa K
    Cancer Lett; 1993 Jul; 71(1-3):103-8. PubMed ID: 8395971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential alteration of proto-oncogene expression in liver, spleen, kidney and brain of mice subjected to whole body irradiation.
    Ogawa Y; Saibara T; Terashima M; Ono M; Hamada N; Nishioka A; Inomata T; Onishi S; Yoshida S; Seguchi H
    Oncology; 1996; 53(5):412-6. PubMed ID: 8784477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.